The future of vaccine manufacturing in Africa. Reminiscent of the 2009 H1N1 Influenza pandemic, the COVID-19 pandemic is perpetuating the stark reality of vaccine insecurity in Africa. Less than 1 percent of all vaccines used on the continent are locally produced—a…
Biovac and Development Partners Collaborate to Support SA’s Vaccine Manufacturing Expansion
Biovac and Development Partners Collaborate to Support South Africa’s Vaccine Manufacturing Expansion and Advance Long-Term Health Security Across Africa. 1 MARCH 2022 – To support South Africa and the African continent increase vaccine manufacturing capacity and reduce reliance on imports, a…
Expanding sustainable vaccine manufacturing in Africa
Expanding sustainable vaccine manufacturing in Africa: Priorities for Support. NOVEMBER 2022, The pandemic has highlighted new and pressing challenges to regional vaccine supply resilience as a critical factor in global health security. While 1.8 billion doses1 of COVID-19 vaccine have been…
Biovac Signs Deal to Develop and Manufacture Oral Cholera Vaccine for African and Global Markets
Biovac Signs Deal to Develop and Manufacture Oral Cholera Vaccine for African and Global Markets. 23 NOVEMBER 2022 – South African based Bio-pharmaceutical company, Biovac, has concluded a ground-breaking licensing and technology transfer agreement with the International Vaccine Institute (IVI), a…
Why vaccine independence is so important for Africa.
Why vaccine independence is so important for Africa. DECEMBER 2022 – During the COVID-19 pandemic, we saw warp-speed development of vaccines in some parts of the world. But for Africa, the pandemic highlighted the urgent need to build capacity on the…
Breaking the cycle: building vaccine manufacturing capacity in Africa
Breaking the cycle: building vaccine manufacturing capacity in Africa. 7 DECEMBER 2022 – On November 8, 2002, Charlotte Barker, Editor, of Vaccine Insights, spoke to Patrick Tippoo about building vaccine manufacturing capacity in Africa. This article has been written based on…
Are African-made vaccines the solution to vaccine inequity?
Are African-made vaccines the solution to vaccine inequity? 12 JANUARY 2023The coronavirus pandemic has highlighted a variety of global health inequalities, prime among them has been the devastating consequences of vaccine inequity. While high-income countries and those with robust vaccine manufacturing…
Is there a regional solution to vaccine inequity?
Is there a regional solution to vaccine inequity? 17 JANUARY 2023 – The COVID-19 pandemic and subsequent global rollout of vaccines revealed the good, the bad and the ugly of the global community’s ability to come together and respond. The good…
Five ways to scale up the African vaccine manufacturing industry
Five ways to scale up the African vaccine manufacturing industry. How can vaccine manufacturers in Africa expand their manufacturing capacity and capabilities? Deborah King, Vaccines Lead at Wellcome, highlights five key areas for support – including access to finance and training opportunities….
Devex CheckUp: Cracking the code on Marburg virus
Devex CheckUp: Cracking the code on Marburg virus. 16 FEBRUARY 2023 – Equatorial Guinea announced its first outbreak this week of the rare and deadly Marburg disease — a hemorrhagic fever similar to Ebola. There are no vaccines or antiviral treatments approved…